|
Neuberg Sehgal Path Lab, a leading name in diagnostic services, has announces the launch of cutting-edge cytogenetics testing technology at its facilities in Mumbai. This advanced diagnostic tool is poised to revolutionise the approach to both cancer diagnostics and prenatal testing, offering a higher level of precision and personalisation for patients.
Cytogenetics, a specialised field that focuses on studying genetic material within cells, is now available at Neuberg Sehgal Path Lab, utilising two powerful techniques: Fluorescent In-Situ Hybridisation (FISH) and Conventional Karyotyping. This technology enables the precise identification of chromosomal abnormalities, including translocations, deletions, and insertions—key indicators of various genetic disorders and cancer types.
A rare offering by standalone labs in India, Cytogenetics is primarily conducted in large, standardized labs such as Tata Medical Center in Kolkata, Tata Memorial in Mumbai, CMC Vellore, and SGPGI in Lucknow.
Cytogenetics offers highly accurate detection of chromosomal abnormalities, aiding in the diagnosis of conditions such as Down syndrome during prenatal testing, as well as a variety of cancers, including acute promyelocytic leukaemia (APML) and Burkitt’s lymphoma.
By identifying genetic mutations, the technology helps in stratifying cancer risks, enabling personalised treatment plans for patients, whether they require intensive chemotherapy or a more conservative approach.
FISH provides rapid results, typically within 3 days, ensuring that patients receive timely and actionable information. Conventional Karyotyping, while more comprehensive, requires around 14 days for results.
The cost of cytogenetic testing is relatively affordable compared to high-end molecular genetics, offering significant value for both prenatal and cancer diagnostics.
Cytogenetics is a labour-intensive process requiring precision and experience. Neuberg Sehgal Path Lab has developed a team of trained specialists led by Dr Simpy Raj – Consultant Hematopathologist and Cytogeneticist with senior scientific officer Dr.Prerna having extensive cytogenetics experience for accurate interpretation of results.
Dr Kunal Sehgal, managing director and chief pathologist, Neuberg Sehgal Path Lab, emphasised the importance of this breakthrough, stating, “The introduction of cytogenetics to our diagnostic offerings strengthens our commitment to providing accurate, affordable, and timely testing for our blood cancer patients. We are excited to offer this technology to the community and ensure that those who require specialised diagnostic testing can access it with ease, all under one roof.”
Cytogenetic testing is recommended for patients undergoing prenatal screenings, those diagnosed with certain cancers, and individuals requiring cancer risk assessments. Neuberg Sehgal Path Lab is among the select few diagnostic providers in the region offering this specialized service along with specialised Bone marrow, Flow Cytometry and molecular testing all under one roof, ensuring high-quality care through a team of trained professionals and advanced diagnostic tools.
Neuberg Diagnostics, headquartered in Chennai, is one of India’s leading diagnostic service providers, with its presence in India, UAE, South Africa, and the USA. With 200 +laboratories accredited by CAP & NABL, Neuberg has emerged as one of the fastest growing and most trusted diagnostic centres in India.
|